Hyperprolactinemia is actually a aspect result of dopamine antagonists as blockade of D2 receptors within the tuberoinfundibular pathway leads to enhanced plasma levels of prolactin due to enhanced secretion by lactotrophs within the anterior pituitary. The effect that symptomatic suppression has